WHO ICTRP trial
Efficacy and Safety of Tibetan Medicine Liuwei Nengxiao Capsule versus Lactulose…
ChiCTR2500106572 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500106572 |
|---|---|
| Public title | Efficacy and Safety of Tibetan Medicine Liuwei Nengxiao Capsule versus Lactulose for Opioid-Induced Constipation (OIC) in Patients with Malignant Tumors: Protocol for a Randomized, Open-Label, Non-Inferiority, Multicenter Clinical Trial |
| Scientific title | Efficacy and Safety of Tibetan Medicine Liuwei Nengxiao Capsule versus Lactulose for Opioid-Induced Constipation (OIC) in Patients with Malignant Tumors: Protocol for a Randomized, Open-Label, Non-Inferiority, Multicenter Clinical Trial |
| Primary sponsor | Chengdu Integrated TCM&Western Medicine Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Opioid-Induced Constipation (OIC) |
| Interventions | Experimental group:Lactulose Oral Solution;Control group:Liuwei Nengxiao capsule |
| Registration date | Jul 25, 2025 |
| Target size | Experimental group:75;Control group:75 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: